372 related articles for article (PubMed ID: 17889519)
1. Transgenic mice expressing D469Delta mutated cartilage oligomeric matrix protein (COMP) show growth plate abnormalities and sternal malformations.
Schmitz M; Niehoff A; Miosge N; Smyth N; Paulsson M; Zaucke F
Matrix Biol; 2008 Mar; 27(2):67-85. PubMed ID: 17889519
[TBL] [Abstract][Full Text] [Related]
2. Chondrocyte cell death and intracellular distribution of COMP and type IX collagen in the pseudoachondroplasia growth plate.
Hecht JT; Makitie O; Hayes E; Haynes R; Susic M; Montufar-Solis D; Duke PJ; Cole WG
J Orthop Res; 2004 Jul; 22(4):759-67. PubMed ID: 15183431
[TBL] [Abstract][Full Text] [Related]
3. Ablation of collagen IX and COMP disrupts epiphyseal cartilage architecture.
Blumbach K; Niehoff A; Paulsson M; Zaucke F
Matrix Biol; 2008 May; 27(4):306-18. PubMed ID: 18191556
[TBL] [Abstract][Full Text] [Related]
4. COMP mutations, chondrocyte function and cartilage matrix.
Hecht JT; Hayes E; Haynes R; Cole WG
Matrix Biol; 2005 Jan; 23(8):525-33. PubMed ID: 15694129
[TBL] [Abstract][Full Text] [Related]
5. Expression of PSACH-associated mutant COMP in tendon fibroblasts leads to increased apoptotic cell death irrespective of the secretory characteristics of mutant COMP.
Weirich C; Keene DR; Kirsch K; Heil M; Neumann E; Dinser R
Matrix Biol; 2007 May; 26(4):314-23. PubMed ID: 17307347
[TBL] [Abstract][Full Text] [Related]
6. Combined role of type IX collagen and cartilage oligomeric matrix protein in cartilage matrix assembly: cartilage oligomeric matrix protein counteracts type IX collagen-induced limitation of cartilage collagen fibril growth in mouse chondrocyte cultures.
Blumbach K; Bastiaansen-Jenniskens YM; DeGroot J; Paulsson M; van Osch GJ; Zaucke F
Arthritis Rheum; 2009 Dec; 60(12):3676-85. PubMed ID: 19950300
[TBL] [Abstract][Full Text] [Related]
7. Cell-type specific trafficking of expressed mutant COMP in a cell culture model for PSACH.
Chen TL; Stevens JW; Cole WG; Hecht JT; Vertel BM
Matrix Biol; 2004 Nov; 23(7):433-44. PubMed ID: 15579310
[TBL] [Abstract][Full Text] [Related]
8. Expression of mutant cartilage oligomeric matrix protein in human chondrocytes induces the pseudoachondroplasia phenotype.
Merritt TM; Alcorn JL; Haynes R; Hecht JT
J Orthop Res; 2006 Apr; 24(4):700-7. PubMed ID: 16514635
[TBL] [Abstract][Full Text] [Related]
9. In vivo human Cartilage oligomeric matrix protein (COMP) promoter activity.
Posey KL; Davies S; Bales ES; Haynes R; Sandell LJ; Hecht JT
Matrix Biol; 2005 Dec; 24(8):539-49. PubMed ID: 16214313
[TBL] [Abstract][Full Text] [Related]
10. Expression of cartilage oligomeric matrix protein (COMP) by embryonic and adult osteoblasts.
Di Cesare PE; Fang C; Leslie MP; Tulli H; Perris R; Carlson CS
J Orthop Res; 2000 Sep; 18(5):713-20. PubMed ID: 11117291
[TBL] [Abstract][Full Text] [Related]
11. Retention of the matricellular protein SPARC in the endoplasmic reticulum of chondrocytes from patients with pseudoachondroplasia.
Hecht JT; Sage EH
J Histochem Cytochem; 2006 Mar; 54(3):269-74. PubMed ID: 16286662
[TBL] [Abstract][Full Text] [Related]
12. Pseudoachondroplasia is caused through both intra- and extracellular pathogenic pathways.
Dinser R; Zaucke F; Kreppel F; Hultenby K; Kochanek S; Paulsson M; Maurer P
J Clin Invest; 2002 Aug; 110(4):505-13. PubMed ID: 12189245
[TBL] [Abstract][Full Text] [Related]
13. Role of TSP-5/COMP in pseudoachondroplasia.
Posey KL; Hayes E; Haynes R; Hecht JT
Int J Biochem Cell Biol; 2004 Jun; 36(6):1005-12. PubMed ID: 15094116
[TBL] [Abstract][Full Text] [Related]
14. Mutation (D472Y) in the type 3 repeat domain of cartilage oligomeric matrix protein affects its early vesicle trafficking in endoplasmic reticulum and induces apoptosis.
Hashimoto Y; Tomiyama T; Yamano Y; Mori H
Am J Pathol; 2003 Jul; 163(1):101-10. PubMed ID: 12819015
[TBL] [Abstract][Full Text] [Related]
15. Altered integration of matrilin-3 into cartilage extracellular matrix in the absence of collagen IX.
Budde B; Blumbach K; Ylöstalo J; Zaucke F; Ehlen HW; Wagener R; Ala-Kokko L; Paulsson M; Bruckner P; Grässel S
Mol Cell Biol; 2005 Dec; 25(23):10465-78. PubMed ID: 16287859
[TBL] [Abstract][Full Text] [Related]
16. A secreted variant of cartilage oligomeric matrix protein carrying a chondrodysplasia-causing mutation (p.H587R) disrupts collagen fibrillogenesis.
Hansen U; Platz N; Becker A; Bruckner P; Paulsson M; Zaucke F
Arthritis Rheum; 2011 Jan; 63(1):159-67. PubMed ID: 20936634
[TBL] [Abstract][Full Text] [Related]
17. Characterization of a pseudoachondroplasia-associated mutation (His587-->Arg) in the C-terminal, collagen-binding domain of cartilage oligomeric matrix protein (COMP).
Spitznagel L; Nitsche DP; Paulsson M; Maurer P; Zaucke F
Biochem J; 2004 Jan; 377(Pt 2):479-87. PubMed ID: 14580238
[TBL] [Abstract][Full Text] [Related]
18. Up-regulation of cartilage oligomeric matrix protein at the onset of articular cartilage degeneration in a transgenic mouse model of osteoarthritis.
Salminen H; Perälä M; Lorenzo P; Saxne T; Heinegård D; Säämänen AM; Vuorio E
Arthritis Rheum; 2000 Aug; 43(8):1742-8. PubMed ID: 10943864
[TBL] [Abstract][Full Text] [Related]
19. COMP mutations: domain-dependent relationship between abnormal chondrocyte trafficking and clinical PSACH and MED phenotypes.
Chen TL; Posey KL; Hecht JT; Vertel BM
J Cell Biochem; 2008 Feb; 103(3):778-87. PubMed ID: 17570134
[TBL] [Abstract][Full Text] [Related]
20. Pseudoachondroplastic dysplasia: an Iowa review from human to mouse.
Stevens JW
Iowa Orthop J; 1999; 19():53-65. PubMed ID: 10847517
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
